Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting?

Credit available for this activity expires: 12/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu